e.g. mhealth
Search Results (1 to 10 of 20 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 8 JMIR Research Protocols
- 5 JMIR Formative Research
- 2 JMIR mHealth and uHealth
- 1 JMIR AI
- 1 JMIR Cancer
- 1 JMIR Dermatology
- 1 JMIR Medical Informatics
- 1 JMIR Nursing
- 0 Journal of Medical Internet Research
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Human Factors
- 0 JMIR Public Health and Surveillance
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
Currently, the median wait time for a transplant is approximately 4 years in the United States, and approximately 5000 patients die every year while being on the transplant waiting list [4]. Living donor kidney transplantation (LDKT) generally provides better outcomes than deceased donor transplants but requires that a potential living donor be made aware that they can donate to a specific patient with end-stage renal disease and offer to do so.
JMIR AI 2025;4:e57319
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section
In some instances, patients may be denied a transplant due to the unavailability of suitable donor corneas. Prolonged waiting times and the inability to perform timely corneal transplantation contribute to elevated health care costs. Individuals with visual impairments may require ongoing medical care, rehabilitation services, and assistive devices, placing a financial burden on both health care systems and individuals [8].
JMIR Form Res 2024;8:e50398
Download Citation: END BibTex RIS
At the University of California, San Francisco (UCSF), a real-world RPM program for lung transplant recipients was launched in 2020 and is currently ongoing [14]. Patients used Bluetooth-enabled home spirometers to monitor pulmonary function and reported results and outcomes using a web-based chat interface.
JMIR Mhealth Uhealth 2024;12:e51236
Download Citation: END BibTex RIS
The first liver transplant (LT) in the world was performed in 1963 [1], but the first successful transplant was carried out by Dr Starzl at the University of Pittsburgh in 1967 [2]. Until the introduction of immunosuppression with cyclosporine in the early 1980s, the survival rate of transplanted patients remained at 20% [3,4]. The 1-year and 5-year patient survival rates have increased to 85% and 70%, respectively, due to advances in surgical and anesthetic techniques and immunosuppression protocols.
JMIR Res Protoc 2023;12:e50091
Download Citation: END BibTex RIS
In the United States, annual hematopoietic stem cell transplant (HCT) surpasses 22,000 procedures annually [1]. While HCT is a potentially curative treatment for many cancers, it has significant morbidity and mortality rates [2]. HCT is a rigorous, strenuous, and time-intensive process that impacts patients’ psychological well-being and their overall quality of life [3].
JMIR Form Res 2023;7:e49806
Download Citation: END BibTex RIS
Transplant patients often require costly and time-intensive multidisciplinary care. While taking immunosuppressive medication, transplant patients are encouraged to establish care with a dermatologist for regular skin cancer screenings as they are 20-100 times more likely to develop skin cancers [2].
JMIR Dermatol 2023;6:e43845
Download Citation: END BibTex RIS
According to the most recent Organ Procurement and Transplantation Network and Scientific Registry of Transplant Recipients Annual Data Review [5], 50% of kidney transplant recipients have stage 3 chronic kidney disease (CKD) or worse at 1 year post transplantation.
JMIR Res Protoc 2022;11(12):e41020
Download Citation: END BibTex RIS
Inclusion criteria
Under the outpatient care of at least one of the following specialist Princess Alexandra Hospital clinics: kidney or liver transplant, chronic kidney disease, hemodialysis, peritoneal dialysis, or hepatology
Have (or be undergoing treatment for) at least one of the features of the metabolic syndrome, as defined by the harmonized criteria [1]:
Elevated blood pressure (or on medication to treat) (systolic blood pressure ≥130 mm Hg and/or diastolic blood pressure ≥85 mm Hg)
Elevated waist circumference
JMIR Res Protoc 2022;11(7):e37556
Download Citation: END BibTex RIS
We implemented the registry in collaboration with the Center for International Blood and Marrow Transplant Research (CIBMTR) and core centers experienced in the conduct of HCT for SCD. Our overarching hypothesis is that HCT for SCD improves the health-related quality of life (HRQOL) and immune function but is associated with gonadal damage and impaired fertility potential compared to nontransplanted controls with SCD and sibling controls without SCD.
JMIR Res Protoc 2022;11(7):e36780
Download Citation: END BibTex RIS